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RV and pencardium, have also been proposed as a mechanism of benefit from CRT. We 
set out to determine if the presence of a restrictive mitral filling pattern, known to be a 
marker of DVI, might identify patients more likely to respond to BVP. 
Methods: 19 patients with severe heart failure, LBBB (QRS >lZOms) and fractional short- 
ening (FS%) ~25% were studied before and 6 months after CRT. 
Results: NYHA class improved from 3.4+/-0.3 to 2.3 +/-0.5 (p=O.OOl) after pacing. 
Patients were divided into responders (n=lO, 53%) and non-responders (n=9, 47%) 
based on >5% improvement in FS after pacing. E/A had a stronger correlation than base- 
line QRS with response (r=O.72, p=O.OOl). and remained strongly related when consid- 
ered in combination with other variables. An E/A ~2.0 had a sensitivity of 70% specificity 
of 100% and a predictive value of 100% for determining a positive response to pacing. 
Response to pacing was associated with a significant reduction in E/A (p=O.O3). 
Conclusions: Patients with restrictive mitral Doppler filling patterns (marker of DVI) are 
more likely to show improvements in LV systolic function after CRT. By permitting the LV 
to fill before the RV thus ameliorating DVI. CRT may allow improved LV filling and LV 
systolic function. 
duration and LV volumes was assessed using Kruskall-Wallis non-parametric testing. 
Results: Mean LV EF was 29 f 8 %, mean LV end diastolic volume (EDV) was 200 * 75 
ml, mean LV end systolic volume (ESV) was 146 * 60 ml and mean QRS duration was 
125 r 30 ms. Pts with longer QRS duration had highly significant lower LV EF (p=O.OOZ) 
and higher LV end diastolic and end systolic volumes (both p < 0.001). Means and 95 % 
confidence intewals for LV EF. LV EDV and LV ESV are shown in the figure. 
Conclusion: In patients with heart failure due to CAD, QRS duration on the resting ECG 
is strongly related to LV volumes and LV EF. Therefore, QRS duration is an easily obtain- 
able marker of possible LV dilatation in these patients. 
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Left ventricular pacing (LVP) is thought to improve cardiac function primarily by systolic 
resynchronisation. Our observation that patients with a short QRS duration also benefit 
from LVP suggests alternative mechanisms may also be involved. We hypothesised that 
LVP may influence diastolic filling by inducing a phase shift where by the LV filling occurs 
before right ventricular filling and that this would result in a beneficial reduction in exter- 
nal constraint to LV filling. We present data from 9 heart failure patients with mean left 
ventricular end diastolic pressure (LVEDP) of 21 .S*lOmmHg and QRS duration of 
143+34ms (range, 60-162ms). Simultaneous invasive, micro manometer pressure and 
conductance catheter volume analysis were performed to assess the end diastolic pres- 
sure volume relation during acute right ventricular volume unloading by inferior vena 
caval occlusion. External constraint is defined as the amount by which the LVEDP can be 
reduced without reducing LV end diastolic volume (LVEDV). During LVP, external con- 
straint was reduced from 6.2+4.6mmHg to 3.1+3.7mmHg (p<O.Ol). This removal of 
external constraint by LVP resulted in a 4.1+3.3% increase in LVEDV (p=O.O17), which 
occurred without a slgniflcant rise in LV end systolic volume (0.2+6.5%, pEO.94) resulting 
in an increase in stroke volume of 12.5*11% (p=O.O4). This improvement in stroke vol- 
ume was associated with a rise in dpidt max from 659.7+371 to 767r316 (p=O.O5). We 
conclude that the relief of external constraint to LV filling improves the effective preload 
and allows the use of the Frank-Starling mechanism to improve contractile function and 
cardiac output, of particular potential importance during exercise. 
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Backaround: Both QRS duration and left ventricular (LV) volumes provide prognostic 
information in patlents with heart failure due to coronary artery disease (CAD). The aim 
of this study was to investigate a possible relationship between these parameters. 
Methods: We investigated 277 consecutive patients (246 males, age 65 + 10 years) with 
CAD and LV ejection fraction (EF) < 40 %. All patients underwent a stress-rest myocar- 
dial perfusion gated SPECT study: LV volumes and EF in resting condition were deter- 
mined using QGS” software (Cedars-Sinai, LA, California). QRS duration was measured 
from the resting ECG. Patients were categorized in 6 groups according to QRS duration 
(~100; 100-119; 120-139; 140-159; 160-179; 2160 ms). Relationship between QRS 
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Background: Cardiac resynchronization (CR) pacing therapy as evaluated in the Multi- 
center InSync Randomized Clinical Evaluation (MIRACLE) trial has been shown to result 
in symptomatic improvements in patients with overt heart failure and ventricular dysyn- 
chrony. Neurohormonal (NH) activation during CR was evaluated, recognizing that NH 
mechanisms may serve as prognostic indicators of patient status and/or ventricular 
remodeling. 
Methods: NH measurements were perfomed at baseline prior to implantation of an atrial 
synchronous biventricular pacing device. Patients were randomized to control pacing off 
(C, n=225) or treatment pacing on (P, n=226) groups. NHs were repeated at 3 and 6 
months. Tests included brain natriuretic peptide (BNP), cyclic guanosine monophosphate 
(cGMP), norepinephrine. epinephdne, dopamine, big endothelin (BigET), tumor necrosis 
factor, plasma renin activity and aldosterone. Differences between groups were analyzed 
by Mann-Whitney-U; changes within groups by Wilcoxon’s rank sum test (p.zO.05 consid- 
ered significant). 
Results: There were no significant baseline differences in NHs between groups. 
Changes in NHs at 3 months were not significant between groups. Changes in NHs at 6 
months between groups were significant for cGMP only (p=O.OZ). Significant within group 
changes at 3 months showed decreased BNP in P (p=O.O19); increased BigET in C 
(p.zO.01) and P (p=O.O4). Significant within group changes at 6 months showed 
decreased BNP in C (peO.01) and P (pcO.01); decreased cGMP in P (p=O.OZ): and 
increased BigET in C (pcO.01) and P (p<O.Ol). 
Conclusion: In this patient population, cGMP was significantly reduced in the paced 
group at 6 months suggesting a potential reduction in natriuratic peptide activation. Other 
NHs appeared to respond similarly over time between groups. At 6 months these results 
suggest that these NHs are not significantly changed in response to CR. 
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Background: Accumulation of collagen in the cardiac lnterstitium (reactive interstitial 
fibrosis, RIF) occurs in heart failure (HF) and contributes to LV dysfunction. Matrix metal- 
loproteinases (MMPs) are upregulated in HF and can mediate RIF. In dogs with HF, the 
Acorn Cardiac Support Device &SD), a preformed polyester device surgically placed 
over the ventricles, was shown to reduce LV volume and increase ejection fraction. We 
also showed that chronic CSD therapy reduces RIF and preserves matrix cross-link 
(MCL) integrity in dogs with HF. This study examined the effects of the CSD on gene 
expression of MMP2 and 9 (gelatinases) and on tissue inhibitors of MMPs (TIMPs). 
Methods: The CSD was implanted in 6 dogs with microembolization-induced HF. Six 
other HF dogs sewed as controls. All dogs were followed for 3 months. LV tissue from all 
HF dogs and 6 normal (NL) ddgs was used to extract total RNA. mRNA expression for 
MMPZ and 9 and TlMPl and 2 was measured using teverse transcriptase polymerase 
chain reaction and bands quatified in densitometric units. Results: Results ate shown in 
the table.There were no differences in expression of TlMPl and 2 among the groups. 
Expression of MMPP and 9 was upregulated in HF compared to NL. Therapy with the 
CSD reduced expression of MMP2 and 9 compared to HF controls. Conclusions: 
Chronic therapy with the CSD does not influence TlMPs but reduces expression of 
MMPP and 9. a finding consistent with reduced RIF and preserved MCL integrity I” dogs 
with HF followmg chronic CSD therapy. 
